ENZON PHARMACEUTICALS$6.28
+0.12
| Last Trade: |
6.28 |
| Trade Time: |
May 25 11:59 AM Eastern Daylight Time |
| Change: |
0.12 (1.91 %) |
| Prev Close: |
6.16 |
| Open: |
6.17 |
| Bid: |
6.27 |
| Ask: |
6.28 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
12 Mo. Price Change : -40% - ENZN has underperformed the S&P 500 by 40%
Get Trend Analysis
|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
3/15/2012
|
Young Richard A
|
Director
|
-2,000
|
$6.92
|
-9.28%
|
|
11/10/2011
|
Rackear Andrew D.
|
VP and General Counsel
|
-3,766
|
$6.68
|
-7.23%
|
|
11/8/2011
|
Buchbinder Aby
|
VP, Clinical Development
|
-2,700
|
$7.06
|
-4.76%
|
|
9/15/2011
|
Buchbinder Aby
|
VP, Clinical Development
|
-2,952
|
$8.33
|
-4.95%
|
|
9/15/2011
|
Greenberger Lee M
|
VP, Research
|
-591
|
$8.33
|
-1.78%
|
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (ENZN), click here.
Free Reports
|
|
